PACS Group (NYSE:PACS) CEO Jason Hulse Murray Sells 91,306 Shares

PACS Group, Inc. (NYSE:PACSGet Free Report) CEO Jason Hulse Murray sold 91,306 shares of the company’s stock in a transaction on Thursday, August 20th. The stock was sold at an average price of $43.92, for a total value of $4,010,159.52. Following the sale, the chief executive officer directly owned 54,754,110 shares in the company, valued at $2,404,800,511.20. This represents a 0.17% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jason Hulse Murray also recently made the following trade(s):

  • On Friday, August 21st, Jason Hulse Murray sold 59,244 shares of PACS Group stock. The shares were sold at an average price of $43.90, for a total value of $2,600,811.60.
  • On Wednesday, August 19th, Jason Hulse Murray sold 84,717 shares of PACS Group stock. The stock was sold at an average price of $44.26, for a total value of $3,749,574.42.
  • On Tuesday, August 18th, Jason Hulse Murray sold 66,797 shares of PACS Group stock. The stock was sold at an average price of $44.18, for a total value of $2,951,091.46.
  • On Monday, August 17th, Jason Hulse Murray sold 84,602 shares of PACS Group stock. The shares were sold at an average price of $44.16, for a total value of $3,736,024.32.

PACS Group Stock Performance

Shares of PACS opened at $44.28 on Tuesday. PACS Group, Inc. has a 1 year low of $7.50 and a 1 year high of $49.49. The stock has a market capitalization of $7.01 billion, a PE ratio of 25.75, a PEG ratio of 1.25 and a beta of -0.08. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.91 and a current ratio of 0.91. The stock has a 50-day simple moving average of $43.70 and a 200-day simple moving average of $38.60.

PACS Group (NYSE:PACSGet Free Report) last released its earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.09. PACS Group had a net margin of 4.85% and a return on equity of 29.55%. The firm had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.41 billion. On average, analysts predict that PACS Group, Inc. will post 2.36 earnings per share for the current fiscal year.

Hedge Funds Weigh In On PACS Group

Several hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. lifted its holdings in shares of PACS Group by 14.4% in the 4th quarter. Vanguard Group Inc. now owns 4,506,227 shares of the company’s stock valued at $172,994,000 after purchasing an additional 566,502 shares during the last quarter. Alyeska Investment Group L.P. grew its stake in PACS Group by 159.5% during the 4th quarter. Alyeska Investment Group L.P. now owns 2,250,007 shares of the company’s stock worth $86,378,000 after buying an additional 1,382,984 shares during the last quarter. California State Teachers Retirement System grew its stake in PACS Group by 3,298.3% during the 2nd quarter. California State Teachers Retirement System now owns 1,917,094 shares of the company’s stock worth $81,745,000 after buying an additional 1,860,680 shares during the last quarter. Balyasny Asset Management L.P. increased its position in PACS Group by 67.3% during the third quarter. Balyasny Asset Management L.P. now owns 1,356,240 shares of the company’s stock worth $18,621,000 after buying an additional 545,348 shares during the period. Finally, Ameriprise Financial Inc. increased its position in PACS Group by 19.6% during the third quarter. Ameriprise Financial Inc. now owns 1,350,551 shares of the company’s stock worth $18,543,000 after buying an additional 220,939 shares during the period.

Analyst Upgrades and Downgrades

Several research firms recently commented on PACS. Wall Street Zen lowered PACS Group from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 8th. Zacks Research raised PACS Group from a “hold” rating to a “strong-buy” rating in a report on Monday, August 10th. Royal Bank Of Canada upped their price objective on PACS Group from $52.00 to $57.00 and gave the stock an “outperform” rating in a research report on Thursday, August 6th. Truist Financial increased their price objective on PACS Group from $52.00 to $62.00 and gave the company a “buy” rating in a report on Thursday, August 6th. Finally, UBS Group raised their target price on PACS Group from $57.00 to $60.00 and gave the stock a “buy” rating in a research report on Thursday, August 6th. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus target price of $56.00.

Check Out Our Latest Analysis on PACS Group

PACS Group Company Profile

(Get Free Report)

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.

See Also

Insider Buying and Selling by Quarter for PACS Group (NYSE:PACS)

Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.